TEXAS — On the heels of a joint statement made by the Food and Drug Administration and the Centers for Disease Control and Prevention Tuesday morning, the Texas Department of State Health Services has asked all vaccine providers in the state to abstain from administering the Johnson & Johnson COVID-19 vaccine for the time being.

What You Need To Know

  • DSHS asking Texas providers to pause Johnson & Johnson COVID-19 vaccine administration

  • Move comes on the heels of a joint statement from the FDA and CDC

  • Agencies say six U.S. recipients of the Johnson & Johnson vaccine developed blood clots

  • Millions of doses of J&J vaccine have been administered in the U.S. without issue 

The FDA and CDC recommended Johnson & Johnson vaccine distribution be paused after six U.S. recipients of it developed a condition involving blood clots. It has been pointed out by U.S. health agencies, however, that more than 6.8 million doses of the vaccine have been administered in the country, making the condition extremely rare.

DSHS in a news release Tuesday said Johnson & Johnson vaccine recipients who develop severe headaches, abdominal pain, leg pain or shortness of breath within three weeks of injection should contact their health care providers.

The agency further said it does not appear that any of the patients who developed blood clots are located in Texas and that so far more than 500,000 Johnson & Johnson doses have been administered in the state.

Related Stories

Texas providers are asked to continue storing the Johnson & Johnson vaccine in proper conditions while awaiting further guidance from DSHS.

-

Facebook Twitter